Your browser doesn't support javascript.
loading
Repurposing anticancer drugs for the management of COVID-19.
El Bairi, Khalid; Trapani, Dario; Petrillo, Angelica; Le Page, Cécile; Zbakh, Hanaa; Daniele, Bruno; Belbaraka, Rhizlane; Curigliano, Giuseppe; Afqir, Said.
Afiliación
  • El Bairi K; Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco. Electronic address: k.elbairi@ump.ac.ma.
  • Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.
  • Petrillo A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy; University of Study of Campania "L.Vanvitelli", Naples, Italy.
  • Le Page C; Research Institute of McGill University Health Center (RI-MUHC), Montréal, QC, Canada.
  • Zbakh H; Center of Marine Sciences, University of Algarve, Ed. 7, Campus of Gambelas, 8005-139, Faro, Portugal.
  • Daniele B; Medical Oncology Unit, Ospedale del Mare, Naples, Italy.
  • Belbaraka R; Department of Medical Oncology, "Bioscience et Santé" Research Laboratory, Faculty of Medicine, Cadi Ayad University, Marrakesh, Morocco.
  • Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; University of Milan, Department of Oncology and Hematology, Milan, Italy.
  • Afqir S; Department of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.
Eur J Cancer ; 141: 40-61, 2020 12.
Article en En | MEDLINE | ID: mdl-33125946

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Antineoplásicos Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Antineoplásicos Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article